E-Learning for Rare Diseases: An Example Using Fabry Disease
Background: Rare diseases represent a challenge for physicians because patients are rarely seen, and they can manifest with symptoms similar to those of common diseases. In this work, genetic confirmation of diagnosis is derived from DNA sequencing. We present a tutorial for the molecular analysis o...
Main Authors: | Chiara Cimmaruta, Ludovica Liguori, Maria Monticelli, Giuseppina Andreotti, Valentina Citro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/10/2049 |
Similar Items
-
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations
by: Valentina Citro, et al.
Published: (2016-12-01) -
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase
by: Chiara Cimmaruta, et al.
Published: (2018-11-01) -
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease
by: Jan Lukas, et al.
Published: (2020-01-01) -
Human α-Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease
by: Andrea Modrego, et al.
Published: (2021-06-01) -
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
by: Maria Monticelli, et al.
Published: (2019-08-01)